TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 226 filers reported holding TG THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.78 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $8,348,724 | +3610.5% | 336,100 | +2744.4% | 0.18% | +3560.0% |
| Q4 2021 | $225,000 | -67.9% | 11,816 | -43.9% | 0.01% | -73.7% |
| Q3 2021 | $701,000 | -18.1% | 21,069 | -4.5% | 0.02% | -29.6% |
| Q2 2021 | $856,000 | +321.7% | 22,068 | +423.1% | 0.03% | +237.5% |
| Q1 2021 | $203,000 | -65.1% | 4,219 | -92.0% | 0.01% | -84.3% |
| Q4 2019 | $582,000 | +12.4% | 52,426 | -12.5% | 0.05% | +8.5% |
| Q2 2019 | $518,000 | +482.0% | 59,934 | +175.3% | 0.05% | +261.5% |
| Q4 2018 | $89,000 | -60.1% | 21,772 | -45.4% | 0.01% | -40.9% |
| Q3 2018 | $223,000 | – | 39,865 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,890,000 | $15,800,400 | 5.14% |
| Ghost Tree Capital, LLC | 1,000,000 | $8,360,000 | 2.75% |
| Soleus Capital Management, L.P. | 2,884,382 | $24,113,434 | 2.22% |
| M28 Capital Management LP | 216,600 | $1,810,776 | 2.08% |
| Paradigm Biocapital Advisors LP | 3,619,015 | $30,254,965 | 2.05% |
| 683 Capital Management, LLC | 1,350,000 | $11,286,000 | 0.88% |
| Parkwood LLC | 165,414 | $6,081 | 0.66% |
| Spotlight Asset Group, Inc. | 79,000 | $660,440 | 0.60% |
| Pier Capital, LLC | 392,709 | $3,283,047 | 0.53% |
| Quantum Private Wealth, LLC | 91,081 | $761,438 | 0.36% |